Biomarker Identification in Breast Cancer: Beta-Adrenergic Receptor Signaling and Pathways to Therapeutic Response

Recent preclinical studies have associated beta-adrenergic receptor (β-AR) signaling with breast cancer pathways such as progression and metastasis. These findings have been supported by clinical and epidemiological studies which examined the effect of beta-blocker therapy on breast cancer metastasi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kafetzopoulou, Liana E., Boocock, David J., Dhondalay, Gopal Krishna R., Powe, Desmond G., Ball, Graham R.
Format: Artigo
Idioma:Inglês
Publicat: Research Network of Computational and Structural Biotechnology (RNCSB) Organization 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3962150/
https://ncbi.nlm.nih.gov/pubmed/24688711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5936/csbj.201303003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars